Prostate Cancer

The Pharmacy Times® Prostate Cancer Resource Center is a comprehensive resource for clinical news and expert insights on issues related to cancer that occurs in the prostate.

Latest News

Image Credit: © Jo Panuwat D - stock.adobe.com
FoundationOne Liquid CDx Receives FDA Approval as a Diagnostic Tool for Patients With BRCA-Mutated mCRPC

July 2nd 2024

FoundationOne Liquid CDx can be used to identify niraparib and abiraterone acetate eligibility in patients with metastatic castration-resistant prostate cancer (mCRPC).

Man Hands holding blue ribbon over blue sky, Prostate Cancer Awareness, November blue, Movember Men health awareness - Image credit: SewcreamStudio | stock.adobe.com
FDA Grants Fast Track Designation to SYNC-T SV-102 for Metastatic Castration-Resistant Prostate Cancer

July 1st 2024

Blue ribbon for prostate cancer awareness -- Image credit: ActionGP | stock.adobe.com
A New Frontier: PARP Inhibitors Plus Antiandrogens in BRCA- or HRR-Mutated mCRPC

February 21st 2024

3d rendered illustration of the anatomy of a cancer cell | Image Credit: SciePro - stock.adobe.com
FDA Approves Enzalutamide for Nonmetastatic Castration-Sensitive Prostate Cancer

November 17th 2023

Video Interviews
Podcasts

More News

© 2024 MJH Life Sciences

All rights reserved.